Cleared Traditional

K150413 - QB1 System Powered Muscle Stimulator & Transcutaneous Electrical Nerve Stimulator

K150413 is an FDA 510(k) clearance for QB1 System Powered Muscle Stimulator & ..., manufactured by Cymedica Orthopedics, Inc.. The device is a Class 2 Physical Medicine device with product code IPF cleared through the Traditional 510(k) pathway after a 43-day FDA review.

K150413 · Cymedica Orthopedics, Inc. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2015
Decision
43d
Days
Class 2
Risk

K150413 is an FDA 510(k) clearance for the QB1 System Powered Muscle Stimulator & Transcutaneous Electrical Nerve Stimul.... Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.

Submitted by Cymedica Orthopedics, Inc. (Scottsdale, US). The FDA issued a Cleared decision on April 2, 2015 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cymedica Orthopedics, Inc. devices

FDA 510(k) Submission Details - K150413

510(k) Number K150413 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2015
Decision Date April 02, 2015
Days to Decision 43 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 116d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

IPF Device Classification - Class 2, Special Controls

Product Code IPF Stimulator, Muscle, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Consultant

Third Party Review Group, LLC
DAVE YUNGVIRT

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IPF Stimulator, Muscle, Powered

All 322
Devices cleared under the same product code (IPF) and FDA review panel - the closest regulatory comparables to K150413.
VitalStim(R) Plus Electrotherapy System
K153224 · Djo, LLC · Feb 2016
geko T-2 Neuromuscular Stimulator
K152677 · Firstkind Limited · Oct 2015
Muscle Stimulation System 110
K150742 · Niveus Medical, Inc. · Jul 2015
FLEX-MT +
K140467 · Emsi · Oct 2014
GEKO
K133638 · Firstkind Limited · Aug 2014
NEURODYN COMPACT, NEURODYN II
K131917 · Ibramed Equipamentos Medicos · Apr 2014

FDA 510(k) Resources - Physical Medicine

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.